Details

---

Manufacturer
RANBAXY (MALAYSIA) SDN. BHD.
 
Contents
Metformin HCl
 
Indication
Type 2 diabetes mellitus.
 
Instruction
Should be taken with food.
 
Drug interaction
Increased risk of hypoglycaemia with insulin and insulin secretagogues (e.g. sulfonylurea). Increased risk of lactic acidosis with carbonic anhydrase inhibitors (e.g. acetazolamide, dichlorphenamide), NSAIDs, and antihypertensive agents (e.g. ACE inhibitors). Increased plasma concentration and reduced clearance with OCT2 inhibitors (e.g. cimetidine, dolutegravir, ranolazine, trimethoprim, vandetanib, isavuconazole). Potentially Fatal: Contrast-induced nephropathy and increased risk of lactic acidosis with iodinated contrast agents